EMA awards coveted PRIME designation for Janssen's CAR-T therapy
Lumateperone effektiv und sicher bei Schizophrenie | Gelbe Liste
EMA's CHMP recommends four new meds for approval at its December meeti
Lurasidone - Wikipedia
Diurnal withdraws EMA orphan designation request for Efmody/Chronocort
Lumateperone | New Drug Approvals
Lumateperone | New Drug Approvals
EMA again rejects Kyowa Kirin's MA for istradefylline for 'OFF' episod
Intra-Cellular Therapies, Inc.
Synthetic Approaches to the New Drugs Approved during 2019 | Journal of Medicinal Chemistry
lumateperone
EMA starts rolling review of COVID-19 vaccine Vidprevtyn
Lumateperone | New Drug Approvals
Lumateperone: Informazioni sul nuovo antipsicotico - Valerio Rosso
Albireo files for FDA and EMA approval of odevixibat for PFIC
Lumateperone | New Drug Approvals
Depressione nel disturbo bipolare, efficace in fase 3 lumateperone
EMA/CHMP recommendations on drug indication extensions
EMA experts meet with African regulators to discuss opportunities for
PDF) Lumateperone tosylate, A Selective and Concurrent Modulator of Serotonin, Dopamine, and Glutamate, in the Treatment of Schizophrenia
New medicines recommended for approval by EMA's CHMP in March
ViiV nabs EMA marketing authorization for multidrug-resistant HIV
